Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Accumulated Expenses: 2009-2021

Historic Other Accumulated Expenses for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $5.3 million.

  • Avadel Pharmaceuticals' Other Accumulated Expenses rose 155.40% to $3.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $3.8 million, marking a year-over-year increase of 155.40%. This contributed to the annual value of $5.3 million for FY2021, which is 1.35% up from last year.
  • As of FY2021, Avadel Pharmaceuticals' Other Accumulated Expenses stood at $5.3 million, which was up 1.35% from $5.2 million recorded in FY2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Other Accumulated Expenses peaked at $5.3 million during FY2021, and registered a low of $597,000 during FY2017.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $5.2 million (2020), whereas its average is $4.8 million.
  • Data for Avadel Pharmaceuticals' Other Accumulated Expenses shows a peak YoY surged of 509.72% (in 2018) over the last 5 years.
  • Avadel Pharmaceuticals' Other Accumulated Expenses (Yearly) stood at $597,000 in 2017, then skyrocketed by 509.72% to $3.6 million in 2018, then grew by 6.46% to $3.9 million in 2019, then spiked by 34.19% to $5.2 million in 2020, then climbed by 1.35% to $5.3 million in 2021.